Mettler-Toledo: Precision Technology Benefits from Pharma Boom
Reading Time: 3 minutes
Q2 results impress: Mettler-Toledo beats earnings expectations and raises the annual guidance for earnings per share. Beneficiary of GLP-1 & mRNA: Increasing R&D budgets in the biotech and pharmaceutical sector fuel demand for high-precision instruments. High trading volume: First-class pricing power and recurring revenues from pipette tips attract institutional investors. A notable increase in high trading volume signals a clear re-accumulation pattern by institutional investors in the stock of Mettler-Toledo International...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
